115 related articles for article (PubMed ID: 16114855)
1. [Nude stents, coated stents].
Puel J
Bull Acad Natl Med; 2005 Feb; 189(2):237-47. PubMed ID: 16114855
[TBL] [Abstract][Full Text] [Related]
2. The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?
Beyar R; Roguin A
Eur Heart J; 2001 Nov; 22(22):2054-7. PubMed ID: 11686663
[No Abstract] [Full Text] [Related]
3. Role of stent design and coatings on restenosis and thrombosis.
Hara H; Nakamura M; Palmaz JC; Schwartz RS
Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
[TBL] [Abstract][Full Text] [Related]
4. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
6. Covered stents: a review.
Jamshidi P; Mahmoody K; Erne P
Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
[TBL] [Abstract][Full Text] [Related]
7. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
9. Promise and challenges of bioabsorbable stents.
Waksman R
Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
11. Preventing restenosis with stent drug coatings.
Belardi J
J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
[No Abstract] [Full Text] [Related]
12. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
13. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
14. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
15. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review.
Yan BP; Ajani AE; Waksman R
Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355
[TBL] [Abstract][Full Text] [Related]
17. Is the bioabsorbable stent an answer for late stent thrombosis.
Nanjundappa A; Mandapaka S; Dieter RS
J Invasive Cardiol; 2007 Apr; 19(4):186-7. PubMed ID: 17404405
[No Abstract] [Full Text] [Related]
18. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
19. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
Scott NA
Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
La Manna A; Capodanno D; Cera M; Di Salvo ME; Sacchetta G; Corcos T; Prati F; Tamburino C
Am J Cardiol; 2009 Jun; 103(11):1551-5. PubMed ID: 19463514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
